Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	315.65	202.02	48.60
Graham Fair Price	-92.07	0.88	11.10
PEG	12155.99	37.11	0.30
Price/Book	27.34	2.67	2.09
Price/Cash Flow	-88.49	41.19	-357.80
Prices/Earnings	19635.28	-3735.10	18.93
Price/Sales	50.89	10.40	6.89
Price/FCF	-88.49	41.19	-357.80
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.20	0.59	0.59
Operating Margin	-82.80	0.02	0.09
ROA	-99.35	< 0.005	0.01
ROE	0.03	< 0.005	-99.35
ROIC	0.02	< 0.005	-99.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.01	83.13
Dividends QOQ	< 0.005	< 0.005	7.45
EBIT QOQ	0.43	-0.86	96.63
EPS QOQ	0.63	-1.01	61.03
FCF QOQ	-1.09	12.03	1002.85
Revenue QOQ	-0.02	-0.16	-570.06
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	153.72	184.27	19.87
Days Sales Outstanding (DSO)	68.85	63.84	-7.29
Inventory Turnover	0.59	0.49	-16.58
Debt/Capitalization	0.30	0.28	-4.47
Quick Ratio	1.07	1.03	-3.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.07	13.89	-1.31
Cash	3.78	3.94	4.21
Capex	-0.11	-0.11	2.73
Free Cash Flow	-0.08	0.90	991.79
Revenue	4.28	3.56	-16.71
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.80	1.74	-3.31
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.06	10.48	242.73
Naive Interpretation	Member

06 - Financial Health · Weak

Rating